FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968418753> ?p ?o ?g. }

• W1968418753 endingPage "209" @default.
• W1968418753 startingPage "201" @default.
• W1968418753 abstract "Nanomedicine, an emerging new field created by the fusion of nanotechnology and medicine, is one of the most promising pathways for the development of effective targeted therapies with oncology being the earlier and the most notable beneficiary to date. Indeed, drug-loaded nanoparticles provide an ideal solution to overcome the low selectivity of the anticancer drugs towards the cancer cells in regards to normal cells and the induced severe side-effects, thanks to their passive and/or active targeting to cancer tissues. Liposome-based systems encapsulating drugs are already used in some cancer therapies (e.g. Myocet, Daunoxome, Doxil). But liposomes have some important drawbacks: they have a low capacity to encapsulate lipophilic drugs (even though it exists), they are manufactured through processes involving organic solvents, and they are leaky, unstable in biological fluids and more generally in aqueous solutions for being commercialized as such. We have developed new nano-cargos, the lipid nanocapsules, with sizes below the endothelium fenestration (ϕ < 100 nm), that solve these disadvantages. They are prepared according to a solvent-free process and they are stable for at least one year in suspension ready for injection, which should reduce considerably the cost and convenience for treatment. Moreover, these new nano-cargos have the ability to encapsulate efficiently lipophilic drugs, offering a pharmaceutical solution for their intravenous administration. The lipid nanocapsules (LNCs) have been prepared according to an original method based on a phase-inversion temperature process recently developed and patented. Their structure is a hybrid between polymeric nanocapsules and liposomes because of their oily core which is surrounded by a tensioactive rigid membrane. They have a lipoprotein-like structure. Their size can be adjusted below 100 nm with a narrow distribution. Importantly, these properties confer great stability to the structure (physical stability > 18 months). Blank or drug-loaded LNCs can be prepared, with or without PEG (polyethyleneglycol)ylation that is a key parameter that affects the vascular residence time of the nano-cargos. Other hydrophilic tails can also be grafted. Different anticancer drugs (paclitaxel, docetaxel, etoposide, hydroxytamoxifen, doxorubicin, etc.) have been encapsulated. They all are released according to a sustained pattern. Preclinical studies on cell cultures and animal models of tumors have been performed, showing promising results." @default.
• W1968418753 created "2016-06-24" @default.
• W1968418753 creator A5032466294 @default.
• W1968418753 creator A5035704254 @default.
• W1968418753 creator A5057987159 @default.
• W1968418753 creator A5068564589 @default.
• W1968418753 date "2009-09-01" @default.
• W1968418753 modified "2023-10-09" @default.
• W1968418753 title "Lipid nanocapsules: A new platform for nanomedicine" @default.
• W1968418753 cites W1205374584 @default.
• W1968418753 cites W1551127380 @default.
• W1968418753 cites W169187846 @default.
• W1968418753 cites W177018918 @default.
• W1968418753 cites W1964598669 @default.
• W1968418753 cites W1964845448 @default.
• W1968418753 cites W1965455284 @default.
• W1968418753 cites W1966095795 @default.
• W1968418753 cites W1966595448 @default.
• W1968418753 cites W1966631624 @default.
• W1968418753 cites W1970030334 @default.
• W1968418753 cites W1972544735 @default.
• W1968418753 cites W1974212595 @default.
• W1968418753 cites W1976794470 @default.
• W1968418753 cites W1981904613 @default.
• W1968418753 cites W1984781096 @default.
• W1968418753 cites W1984820569 @default.
• W1968418753 cites W1986232860 @default.
• W1968418753 cites W1989619366 @default.
• W1968418753 cites W1993612298 @default.
• W1968418753 cites W1993864351 @default.
• W1968418753 cites W1994529552 @default.
• W1968418753 cites W2000182431 @default.
• W1968418753 cites W2001599424 @default.
• W1968418753 cites W2002183466 @default.
• W1968418753 cites W2002516695 @default.
• W1968418753 cites W2005408173 @default.
• W1968418753 cites W2005542583 @default.
• W1968418753 cites W2007648100 @default.
• W1968418753 cites W2009539512 @default.
• W1968418753 cites W2014537537 @default.
• W1968418753 cites W2017817138 @default.
• W1968418753 cites W2021175157 @default.
• W1968418753 cites W2025377771 @default.
• W1968418753 cites W2029124536 @default.
• W1968418753 cites W2031405187 @default.
• W1968418753 cites W2032029382 @default.
• W1968418753 cites W2034518103 @default.
• W1968418753 cites W2039793277 @default.
• W1968418753 cites W2040692230 @default.
• W1968418753 cites W2043707675 @default.
• W1968418753 cites W204512410 @default.
• W1968418753 cites W2048428129 @default.
• W1968418753 cites W2048933340 @default.
• W1968418753 cites W2051137616 @default.
• W1968418753 cites W2052884059 @default.
• W1968418753 cites W2053276138 @default.
• W1968418753 cites W2055475004 @default.
• W1968418753 cites W2057660274 @default.
• W1968418753 cites W2058958377 @default.
• W1968418753 cites W2061346349 @default.
• W1968418753 cites W2062307956 @default.
• W1968418753 cites W2065301357 @default.
• W1968418753 cites W2066912376 @default.
• W1968418753 cites W2067797856 @default.
• W1968418753 cites W2076941870 @default.
• W1968418753 cites W2082865634 @default.
• W1968418753 cites W2084652077 @default.
• W1968418753 cites W2087020662 @default.
• W1968418753 cites W2099029222 @default.
• W1968418753 cites W2099431752 @default.
• W1968418753 cites W2100958444 @default.
• W1968418753 cites W2101099825 @default.
• W1968418753 cites W2111132988 @default.
• W1968418753 cites W2111465078 @default.
• W1968418753 cites W2135062838 @default.
• W1968418753 cites W2143336736 @default.
• W1968418753 cites W2146237608 @default.
• W1968418753 cites W2150471474 @default.
• W1968418753 cites W2162909204 @default.
• W1968418753 cites W2171792381 @default.
• W1968418753 cites W4248435385 @default.
• W1968418753 doi "https://doi.org/10.1016/j.ijpharm.2009.04.026" @default.
• W1968418753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19409468" @default.
• W1968418753 hasPublicationYear "2009" @default.
• W1968418753 type Work @default.
• W1968418753 sameAs 1968418753 @default.
• W1968418753 citedByCount "441" @default.
• W1968418753 countsByYear W19684187532012 @default.
• W1968418753 countsByYear W19684187532013 @default.
• W1968418753 countsByYear W19684187532014 @default.
• W1968418753 countsByYear W19684187532015 @default.
• W1968418753 countsByYear W19684187532016 @default.
• W1968418753 countsByYear W19684187532017 @default.
• W1968418753 countsByYear W19684187532018 @default.
• W1968418753 countsByYear W19684187532019 @default.
• W1968418753 countsByYear W19684187532020 @default.
• W1968418753 countsByYear W19684187532021 @default.
• W1968418753 countsByYear W19684187532022 @default.

• next